PRAC recommends measures to reduce risk of heart problems with Corlentor/Procoralan (ivabradine)

View source ↗

Summary

The EMA's Pharmacovigilance Risk Assessment Committee (PRAC) recommends measures to reduce the risk of heart problems with ivabradine (Corlentor/Procoralan).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Failure
• Stable Angina

Drugs mentioned

• Corlentor (ivabradine hydrochloride)
• Procoralan (Ivabradine)